IL33 and neoplasm: Similarly, IL-33 administration increased tumour-infiltrating IL-13+ ILC2s, MDSCs, and Tregs, and correlated with reduced NK cell cytotoxicity and accelerated tumour growth and metastasis to the lung and liver [177].